10-K Decoder · All companies

Abbott Laboratories

ABT · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$44.3B$42.0B+5.7%
Operating income$8.05B$6.83B+18.0%
Net income$6.50B$13.4B−51.5%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 4, 2026

$Q3 2026Year earlierChange
Revenue$13.0B$11.4B+14.5%
Operating income$1.36B$2.06B−34.0%
Net income$920M$1.64B−44.0%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Abbott's revenue in FY2025?
$44.3B in FY2025 (Fiscal year ended Dec 31, 2025), +5.7% vs $42.0B a year earlier, per its 10-K filed Feb 2026.
Was Abbott profitable in FY2025?
Yes: net income was $6.50B and operating income $8.05B in FY2025.
What was Abbott's revenue in Q3 2026?
$13.0B (+14.5% vs a year earlier), per its Form 10-Q filed Nov 4, 2026.